HemCon Medical Technologies, Inc. and Zeria Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement for HemCon’s Innovative Product Line in Japan

PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies, Inc. (“HemCon”), an innovative developer of advanced medical products, is proud to announce the signing of an exclusive licensing agreement with Zeria Pharmaceuticals Co. Ltd. (“Zeria”), a leading pharmaceutical and consumer healthcare products company. Through this partnership, Zeria will market, distribute, and sell HemCon’s line of revolutionary wound and oral care dressings throughout Japan.